Tag: #Global Trends

Ibex Medical Analytics, a leader in AI-powered pathology, has announced a strategic leadership transition alongside the expansion of its life... Read more

The U.S. Department of Health and Human Services (HHS) has expanded its partnership with biotech firm Manus, providing an additional... Read more

Pluri Biotech has secured a patent from the China National Intellectual Property Administration (CNIPA) for its proprietary 3D immune cell... Read more

Eli Lilly has entered into a $100 million licensing agreement with CSL Ltd. for clazakizumab, a monoclonal antibody designed to... Read more

The psychedelic medicine sector experienced a broad market rally on February 17, 2026, following breakthrough data from Compass Pathways. The... Read more

The U.S. Food and Drug Administration (FDA) has reversed its earlier stance and will now proceed with the regulatory review... Read more

Eli Lilly has announced the success of its Phase 3b Together-PsO trial, demonstrating that combining the obesity medication Zepbound with... Read more

Less than six months after its inaugural approval, Novartis’ oral BTK inhibitor Rhapsido (remibrutinib) is positioning itself to become the... Read more

Pharmaceutical giant Eli Lilly has officially teamed up with the U.S. Olympic & Paralympic Committee (USOPC) to launch and expand... Read more